跳至主要内容
临床试验/IRCT20191104045328N6
IRCT20191104045328N6招募中3 期

Evaluation of Riluzole efficacy on cognitive and functional outcome of severe traumatic brain injury patients

Arak University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 60 years(—)
性别
All

入选标准

  • Patients with severe traumatic brain injury
  • Impenetrable brain injury
  • Age over 16 years
  • Ability to receive medication through the mouth or nasogastric tube
  • Glasgow Coma Scale (GCS) less than 9
  • Having informed consent by family members primarily to participate in the study

排除标准

  • Kidney and liver failure
  • History of severe brain injury (tumor or stroke)
  • Unidentifiable patients

研究者

相似试验